CSU spinoff hopes to bring dog cancer drug to market by 2014

A spinoff of Colorado State University called the Veterinary Emerging Technologies Development Corp., or VetDC, hopes to leverage a $200,000 investment from a nonprofit created to boost the state's biotech industry into enough money to launch trials of a promising chemotherapy drug to treat lymphoma in dogs. About 1.2 million dogs are diagnosed with cancer annually, about 200,000 of them with lymphoma, an aggressive cancer that's often fatal.

View Full Article in:

Coloradoan (Fort Collins, Colo.) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Chief Executive Officer
UCare Minnesota
Minneapolis, MN